Jeffrey S Borer

Jeffrey S Borer

UNVERIFIED PROFILE

Are you Jeffrey S Borer?   Register this Author

Register author
Jeffrey S Borer

Jeffrey S Borer

Publications by authors named "Jeffrey S Borer"

Are you Jeffrey S Borer?   Register this Author

100Publications

2620Reads

44Profile Views

Long-Term Durability of Transcatheter Valves: The Importance of Accurate Data.

JACC Cardiovasc Interv 2020 Jan;13(2):253-256

Members of the International Standards Organization (ISO) Cardiac Valves Standards (ISO 5840) Working Group.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jcin.2019.10.003DOI Listing
January 2020

Survival after Aortic Valve Replacement for Aortic Regurgitation: Prediction from Preoperative Contractility Measurement.

Cardiology 2018 23;140(4):204-212. Epub 2018 Aug 23.

Department of Cardiothoracic Surgery, Weill Medical College of Cornell University, New York, New York, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000490848DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6262682PMC
October 2019

Beneficial effects of ivabradine in patients with heart failure, low ejection fraction, and heart rate above 77 b.p.m.

ESC Heart Fail 2019 Oct 8. Epub 2019 Oct 8.

Montreal Heart Institute, Université de Montréal, 5000 Belanger Street, Montreal, H1T 1C8, Quebec, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ehf2.12513DOI Listing
October 2019

Application of Transcatheter Repair to Tricuspid Regurgitation: Still Looking Through a Dark Glass.

Authors:
Jeffrey S Borer

J Am Coll Cardiol 2019 Apr;73(15):1916-1918

College of Medicine, School of Public Health, SUNY Downstate Medical Center, Brooklyn, New York; Weill Cornell Medicine, New York, New York. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jacc.2019.02.026DOI Listing
April 2019

Atrial Fibrillation and Stroke in Patients with Hypertrophic Cardiomyopathy: Important New Insights.

Thromb Haemost 2019 Mar 13;119(3):355-357. Epub 2019 Feb 13.

Department of Neurology, Johns Hopkins University, Baltimore, Maryland, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1055/s-0039-1678724DOI Listing
March 2019

Raymond John Lipicky, MD.

Authors:
Jeffrey S Borer

Cardiology 2018;139(4):265-266. Epub 2018 Apr 3.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000488037DOI Listing
October 2018

Impact of Beta-Blockade on Cardiac Events in Patients with Chronic Severe Nonischemic Mitral Regurgitation.

Cardiology 2018;139(1):1-6. Epub 2017 Oct 18.

Howard Gilman Institute for Valvular Heart Diseases, State University of New York (SUNY) Downstate Medical Center, Brooklyn, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000481250DOI Listing
September 2018

Incremental benefit of drug therapies for chronic heart failure with reduced ejection fraction: a network meta-analysis.

Eur J Heart Fail 2018 09 19;20(9):1315-1322. Epub 2018 Jun 19.

Department of Molecular and Clinical Medicine, Sahlgrenska Academy, University of Gothenburg, Göteborg, Sweden, and National Heart and Lung Institute, Imperial College, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ejhf.1234DOI Listing
September 2018

Efficacy Profile of Ivabradine in Patients with Heart Failure plus Angina Pectoris.

Cardiology 2017;136(2):138-144. Epub 2016 Sep 10.

The Howard Gilman Institute for Heart Valve Diseases and Schiavone Institute for Cardiovascular Translational Research, SUNY Downstate Medical Center, Brooklyn and New York, N.Y., USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000449243DOI Listing
August 2018

Use and Disuse of Observational Research: The Case of Remote Monitoring in Heart Failure.

Cardiology 2017;137(1):14-19. Epub 2016 Dec 14.

GVM Care & Research, Maria Cecilia Hospital, E.S. Health Science Foundation, Cotignola, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000453655DOI Listing
August 2018

Effect of Aspirin Coadministration on the Safety of Celecoxib, Naproxen, or Ibuprofen.

J Am Coll Cardiol 2018 04;71(16):1741-1751

Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, Ohio; Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, Ohio. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jacc.2018.02.036DOI Listing
April 2018

Cardiovascular Safety of Febuxostat or Allopurinol in Patients with Gout.

N Engl J Med 2018 Mar 12;378(13):1200-1210. Epub 2018 Mar 12.

From the University of Connecticut School of Medicine, Farmington (W.B.W.); the University of Alabama, Birmingham (K.G.S.); University of Chicago Medicine, Chicago (M.A.B.), and Takeda Development Center Americas, Deerfield (B.H., M.C., L.G.) - both in Illinois; the State University of New York, Downstate Medical Center, Brooklyn (J.S.B.); Michigan State University College of Human Medicine, Grand Rapids (P.B.G.); and Johns Hopkins University School of Medicine, Baltimore (A.W.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1710895DOI Listing
March 2018

Duration of chronic heart failure affects outcomes with preserved effects of heart rate reduction with ivabradine: findings from SHIFT.

Eur J Heart Fail 2018 02 12;20(2):373-381. Epub 2017 Oct 12.

Department of Molecular and Clinical Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ejhf.1021DOI Listing
February 2018

Therapeutic Coronary Reperfusion and Reperfusion Injury: An Introduction.

Cardiology 2016 7;135(2):67. Epub 2016 Jun 7.

Schiavone Institute of Cardiovascular Translational Research, State University of New York, Downstate Medical Center and College of Medicine, New York, N.Y., USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000446522DOI Listing
December 2017

Role of Payers in the Development of Cardiovascular Therapeutics: Misalignment Between Approval and Reimbursement.

J Am Coll Cardiol 2017 Dec;70(22):2822-2830

Baylor Heart and Vascular Institute, Baylor University Medical Center, Dallas, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jacc.2017.10.027DOI Listing
December 2017

Therapeutic Coronary Reperfusion and Reperfusion Injury: An Introduction.

Cardiology 2016 5;135(1):13. Epub 2016 May 5.

Schiavone Institute of Cardiovascular Translational Research, State University of New York, Downstate Medical Center and College of Medicine, New York, N.Y., USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000446224DOI Listing
November 2017

Comments on meta-analysis of ivabradine as adjuvant treatment for chronic heart failure by Mizzaci et al.

Int J Cardiol 2017 07 23;239. Epub 2017 Jan 23.

Maria Cecilia Hospital, GVM Care and Research, Ettore Sansavini Health Science Foundation, Cotignola, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijcard.2017.01.078DOI Listing
July 2017

Surgical Treatment of Ischemic Mitral Regurgitation: Valve Repair Versus Replacement.

Curr Cardiol Rep 2017 01;19(1)

Division of Cardiovascular Medicine, State University of New York Downstate Medical Center, Brooklyn, New York, NY, 11203, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11886-017-0813-6DOI Listing
January 2017

Benefits of Heart Rate Slowing With Ivabradine in Patients With Systolic Heart Failure and Coronary Artery Disease.

Am J Cardiol 2016 Dec 15;118(12):1948-1953. Epub 2016 Sep 15.

Universitätsklinikum des Saarlandes, Klinik für Innere Medizin III, Homburg/Saar, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.amjcard.2016.08.089DOI Listing
December 2016

Cardiovascular Safety of Celecoxib, Naproxen, or Ibuprofen for Arthritis.

N Engl J Med 2016 12 13;375(26):2519-29. Epub 2016 Nov 13.

From the Cleveland Clinic, Cleveland (S.E.N., M.E.H., L.M.W., K.E.W., Q.W., V.M., A.M.L.); Western Sydney University, Campbelltown, NSW, Australia (N.D.Y.); Brigham and Women's Hospital, Harvard Medical School, Boston (D.H.S., P.L.); University Hospital Zurich, Zurich, Switzerland (T.F.L., F.R.); Baylor College of Medicine, Veterans Affairs Medical Center, Houston (D.Y.G.); and State University of New York, Downstate Health Sciences Center (J.S.B.) and Pfizer (M.G., B.B., M.F.B., W.B.), New York.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1611593DOI Listing
December 2016

Aortic Valve Surgery for Aortic Regurgitation: The Threshold Is Falling.

Authors:
Jeffrey S Borer

J Am Coll Cardiol 2016 11;68(20):2154-2156

Howard Gilman Institute for Heart Valve Diseases and Schiavone Institute for Cardiovascular Translational Research, State University of New York Downstate Medical Center and College of Medicine, Brooklyn New York. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jacc.2016.09.003DOI Listing
November 2016

Misconceptions and Facts About Mitral Regurgitation.

Am J Med 2016 09 5;129(9):919-23. Epub 2016 Apr 5.

Division of Cardiology, Icahn School of Medicine, Mt Sinai St Luke's Hospital, New York, NY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.amjmed.2016.03.010DOI Listing
September 2016

Heart Rate, Life Expectancy and the Cardiovascular System: Therapeutic Considerations.

Cardiology 2015 15;132(4):199-212. Epub 2015 Aug 15.

Division of Cardiovascular Medicine, The Ohio State University, Columbus, Ohio, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000435947DOI Listing
July 2016

Update on ivabradine for heart failure.

Trends Cardiovasc Med 2016 07 28;26(5):444-9. Epub 2016 Jan 28.

GVM Care&Research, Ettore Sansavini Health Science Foundation, Cotignola, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.tcm.2016.01.004DOI Listing
July 2016

Non-adherence to ivabradine and placebo and outcomes in chronic heart failure: an analysis from SHIFT.

Eur J Heart Fail 2016 06 8;18(6):672-83. Epub 2016 Mar 8.

Istitute of Cardiometabolism and Nutrition (ICAN), Pierre et Marie Curie Paris VI University, La Pitié-Salpétrière Hospital, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ejhf.493DOI Listing
June 2016

Effect of ivabradine on numbers needed to treat for the prevention of recurrent hospitalizations in heart failure patients.

Curr Med Res Opin 2015 11;31(10):1903-9. Epub 2015 Sep 11.

a a Department of Medical Statistics , London School of Hygiene and Tropical Medicine , London , United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1185/03007995.2015.1080155DOI Listing
May 2016

Effect of Combining Ivabradine and β-Blockers: Focus on the Use of Carvedilol in the SHIFT Population.

Cardiology 2015 12;131(4):218-24. Epub 2015 May 12.

Heart Institute, Hospital das Clínicas da Faculdade de Medicina da University of São Paulo, São Paulo, Brazil.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000380812DOI Listing
April 2016

Challenges to Data Monitoring Committees When Regulatory Authorities Intervene.

N Engl J Med 2016 Apr 4;374(16):1580-4. Epub 2016 Apr 4.

From the Department of Molecular and Clinical Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden (K.S.); the National Heart and Lung Institute, Imperial College London (K.S.) and the Department of Medical Statistics, London School of Hygiene and Tropical Medicine (S.P.) - both in London; the Division of Cardiovascular Medicine, Howard Gilman Institute for Heart Valve Disease and Schiavone Institute for Cardiovascular Translational Research, State University of New York Downstate Medical Center, New York (J.S.B.); the University of Michigan School of Medicine, Ann Arbor (B.P.); and the Institut de Cardiologie de Montréal, Université de Montréal, Montreal (J.R.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMsb1601674DOI Listing
April 2016

Efficacy and safety of ivabradine in patients with chronic systolic heart failure and diabetes: an analysis from the SHIFT trial.

Eur J Heart Fail 2015 Dec 16;17(12):1294-301. Epub 2015 Sep 16.

Department of Molecular and Clinical Medicine, Sahlgrenska Academy, University of Gothenburg, Sweden, and National Heart and Lung Institute, Imperial College, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ejhf.347DOI Listing
December 2015

Influence of Cardiovascular and Noncardiovascular Co-morbidities on Outcomes and Treatment Effect of Heart Rate Reduction With Ivabradine in Stable Heart Failure (from the SHIFT Trial).

Am J Cardiol 2015 Dec 9;116(12):1890-7. Epub 2015 Oct 9.

Maria Cecilia Hospital, Gruppo Villa Maria (GVM) Care and Research, Ettore Sansavini Health Science Foundation, Cotignola, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.amjcard.2015.09.029DOI Listing
December 2015

Repeated heart rate measurement and cardiovascular outcomes in left ventricular systolic dysfunction.

Am J Med 2015 Oct 2;128(10):1102-1108.e6. Epub 2015 Jun 2.

National Heart and Lung Institute, Imperial College and Institute of Cardiovascular Medicine and Science and Royal Brompton Hospital, London, United Kingdom; Department of Molecular and Clinical Medicine, University of Gothenburg, Gothenburg, Sweden. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.amjmed.2015.04.042DOI Listing
October 2015

Drug Therapy for Heart Valve Diseases.

Circulation 2015 Sep;132(11):1038-45

From Division of Cardiovascular Medicine, The Howard Gilman Institute for Heart Valve Diseases and the Schiavone Institute for Cardiovascular Translational Research, SUNY Downstate Medical Center, Brooklyn and New York, NY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/CIRCULATIONAHA.115.016006DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4582425PMC
September 2015

Role of oral factor Xa inhibitors after acute coronary syndrome.

Cardiology 2014 7;129(4):224-32. Epub 2014 Nov 7.

Division of Cardiovascular Medicine, State University of New York Downstate Medical Center, New York, N.Y., USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000368747DOI Listing
July 2015

Relation of indirect vasodilator use to prognosis in patients with chronic severe mitral regurgitation.

Cardiology 2014 15;129(4):262-6. Epub 2014 Nov 15.

Howard Gilman Institute for Valvular Heart Diseases, State University of New York (SUNY) Downstate Medical Center, Brooklyn, N.Y., USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000368797DOI Listing
July 2015

Meta-analysis of the relation of body mass index to all-cause and cardiovascular mortality and hospitalization in patients with chronic heart failure.

Am J Cardiol 2015 May 18;115(10):1428-34. Epub 2015 Feb 18.

Division of Cardiovascular Medicine, State University of New York Downstate Medical Center, Brooklyn, New York.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.amjcard.2015.02.024DOI Listing
May 2015

Top ten risk factors for morbidity and mortality in patients with chronic systolic heart failure and elevated heart rate: The SHIFT Risk Model.

Int J Cardiol 2015 Apr 4;184:163-9. Epub 2015 Feb 4.

Department of Molecular and Clinical Medicine, Sahlgrenska Academy, University of Gothenburg, Göteborg, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijcard.2015.02.001DOI Listing
April 2015

Resting heart rate: risk indicator and emerging risk factor in cardiovascular disease.

Am J Med 2015 Mar 15;128(3):219-28. Epub 2014 Oct 15.

Weill Medical College of Cornell University, New York, NY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.amjmed.2014.09.016DOI Listing
March 2015

How many patients will benefit from a new therapy for chronic systolic heart failure, and what difference does it make?

Authors:
Jeffrey S Borer

JACC Heart Fail 2015 Mar 28;3(3):231-3. Epub 2015 Jan 28.

Division of Cardiovascular Medicine, The Howard Gilman Institute for Heart Valve Disease, and the Schiavone Institute for Cardiovascular Translational Research, State University of New York Downstate Medical Center, Brooklyn and New York, New York. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jchf.2014.12.007DOI Listing
March 2015

Clinical evaluation of new heart valve prostheses: update of objective performance criteria.

Ann Thorac Surg 2014 Nov 23;98(5):1865-74. Epub 2014 Sep 23.

Medical Data Research Center, Providence Health and Services, Portland, Oregon.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.athoracsur.2014.05.006DOI Listing
November 2014

Trials of implantable monitoring devices in heart failure: which design is optimal?

Nat Rev Cardiol 2014 Oct 12;11(10):576-85. Epub 2014 Aug 12.

INSERM, Centre d'Investigation Clinique 9501 and Unité 961, 34 Cours Léopold, 54000 Nancy, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nrcardio.2014.114DOI Listing
October 2014

Efficacy and safety of ivabradine in patients with chronic systolic heart failure according to blood pressure level in SHIFT.

Eur J Heart Fail 2014 Jul 24;16(7):810-6. Epub 2014 Jun 24.

Institute of Cardiometabolism and Nutrition (ICAN), Pierre et Marie Curie Paris VI University, La Pitié-Salpétrière Hospital, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ejhf.114DOI Listing
July 2014

Etiology of valvular heart disease in the 21st century.

Cardiology 2013 24;126(3):139-52. Epub 2013 Aug 24.

Division of Cardiovascular Medicine, The Ohio State University, Columbus, Ohio, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000354221DOI Listing
June 2014

Early surgery or watchful waiting for asymptomatic severe degenerative mitral regurgitation: is the answer now clear?

Authors:
Jeffrey S Borer

J Am Coll Cardiol 2014 Jun 30;63(22):2408-10. Epub 2014 Mar 30.

Division of Cardiovascular Medicine, The Howard Gilman Institute for Heart Valve Disease, and the Schiavone Institute for Cardiovascular Translational Research, State University of New York Downstate Medical Center, Brooklyn and New York, New York. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jacc.2014.03.003DOI Listing
June 2014

Risk of atrial fibrillation with use of oral and intravenous bisphosphonates.

Am J Cardiol 2014 Jun 15;113(11):1815-21. Epub 2014 Mar 15.

Department of Medicine, Maimonides Medical Center, Brooklyn, New York.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.amjcard.2014.03.008DOI Listing
June 2014

Off-pump versus on-pump coronary artery bypass grafting in octogenarians: comparison of short-term outcomes and long-term survival.

Cardiology 2013 7;125(3):164-9. Epub 2013 Jun 7.

Division of Cardiothoracic Surgery, Downstate Medical Center, State University of New York, New York, N.Y., USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000350669DOI Listing
March 2014

Efficacy and safety of ivabradine in patients with severe chronic systolic heart failure (from the SHIFT study).

Am J Cardiol 2014 Feb 9;113(3):497-503. Epub 2013 Nov 9.

Department of Molecular and Clinical Medicine, Sahlgrenska Academy, University of Gothenburg, Göteborg, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.amjcard.2013.10.033DOI Listing
February 2014

Drug-induced valve disease and considerations of benefit versus risk.

Authors:
Jeffrey S Borer

Eur Heart J 2013 Dec 15;34(46):3535-7. Epub 2013 Sep 15.

The Howard Gilman, Institute for Heart Valve Diseases, State University of New York Downstate Medical Center, 635 Madison Avenue, New York, NY 10022.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/eurheartj/eht323DOI Listing
December 2013

Efficacy and safety of ivabradine in chronic heart failure across the age spectrum: insights from the SHIFT study.

Eur J Heart Fail 2013 Nov 26;15(11):1296-303. Epub 2013 Jun 26.

Maria Cecilia Hospital, GVM Care and Research, Ettore Sansavini Health Science Foundation, Cotignola, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/eurjhf/hft102DOI Listing
November 2013

Selective heart rate reduction with ivabradine unloads the left ventricle in heart failure patients.

J Am Coll Cardiol 2013 Nov 7;62(21):1977-1985. Epub 2013 Aug 7.

Klinik für Innere Medizin III, Kardiologie, Angiologie und Internistische Intensivmedizin, Universitätsklinikum des Saarlandes, Homburg/Saar, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jacc.2013.07.027DOI Listing
November 2013

Cardiovascular safety of varenicline: patient-level meta-analysis of randomized, blinded, placebo-controlled trials.

Am J Ther 2013 May-Jun;20(3):235-46

Department of Biostatistics, Harvard School of Public Health, Boston, MA 02115, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MJT.0b013e31828d455bDOI Listing
October 2013

Cardiac-resynchronization therapy in heart failure with a narrow QRS complex.

N Engl J Med 2013 Oct 2;369(15):1395-405. Epub 2013 Sep 2.

Clinic for Cardiology, University Hospital Zurich, Zurich, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1306687DOI Listing
October 2013

Should we revise our approach to 'optimal medical therapy'? The case of chronic heart failure.

Eur Heart J 2013 Sep 25;34(36):2792-4. Epub 2013 Jul 25.

Maria Cecilia Hospital - GVM Care and Research, Ettore Sansavini Health Science Foundation, Via Corriera 1, 48010 Cotignola (RA), Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/eurheartj/eht279DOI Listing
September 2013

Nonischemic mitral regurgitation: prognostic value of nonsustained ventricular tachycardia after mitral valve surgery.

Cardiology 2013 20;124(2):108-15. Epub 2013 Feb 20.

Division of Cardiovascular Medicine, Department of Medicine, The Howard Gilman Institute for Heart Valve Disease, State University of New York Downstate Medical Center, Brooklyn, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000347085DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3650723PMC
August 2013

Risk following hospitalization in stable chronic systolic heart failure.

Eur J Heart Fail 2013 Aug 3;15(8):885-91. Epub 2013 Mar 3.

Department of Molecular and Clinical Medicine, Sahlgrenska Academy, University of Gothenburg, Goteborg, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/eurjhf/hft032DOI Listing
August 2013